Chemistry Wealth Management’s Oracle ORCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$349K Sell
2,381
-1,005
-30% -$182K 0.06% 160
2026
Q1
$498K Sell
3,386
-27,301
-89% -$4.44M 0.09% 122
2025
Q4
$5.98M Sell
30,687
-2,858
-9% -$680K 1.12% 17
2025
Q3
$9.43M Sell
33,545
-572
-2% -$146K 1.82% 13
2025
Q2
$7.46M Sell
34,117
-140
-0.4% -$22.6K 1.6% 13
2025
Q1
$4.79M Sell
34,257
-152
-0.4% -$24.7K 1.11% 17
2024
Q4
$5.73M Buy
34,409
+241
+0.7% +$42.8K 1.34% 14
2024
Q3
$5.82M Buy
34,168
+1,457
+4% +$211K 1.38% 13
2024
Q2
$4.62M Sell
32,711
-34
-0.1% -$4.22K 1.19% 16
2024
Q1
$4.11M Sell
32,745
-691
-2% -$79.1K 1.11% 18
2023
Q4
$3.53M Buy
33,436
+129
+0.4% +$14.1K 1.06% 18
2023
Q3
$3.53M Sell
33,307
-163
-0.5% -$18.9K 1.17% 16
2023
Q2
$3.99M Sell
33,470
-75
-0.2% -$7.75K 1.3% 15
2023
Q1
$3.12M Sell
33,545
-72
-0.2% -$6.31K 1.08% 18
2022
Q4
$2.75M Buy
33,617
+118
+0.4% +$8.97K 1.07% 17
2022
Q3
$2.05M Sell
33,499
-64
-0.2% -$4.69K 0.81% 23
2022
Q2
$2.35M Buy
33,563
+376
+1% +$27.5K 0.9% 23
2022
Q1
$2.75M Buy
+33,187
New +$2.69M 0.94% 22

Other funds holding ORCL

Chemistry Wealth Management's ORCL Position: Q2 2026 in Review

Chemistry Wealth Management reduced its Oracle (ORCL) stake by 30% in Q2 2026, selling an estimated $182K and leaving 2,381 shares worth $349K. The position accounts for 0.06% of the portfolio, ranked #160.

Chemistry Wealth Management first reported a position in ORCL in Q1 2022 and has held it in 18 quarters since. The position peaked at $9.43M in Q3 2025. 1,772 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

  • Chemistry Wealth Management held 2,381 shares of Oracle worth $349K as of Q2 2026.
  • Chemistry Wealth Management sold 1,005 Oracle shares in Q2 2026, an estimated $182K.
  • Oracle made up 0.06% of Chemistry Wealth Management's portfolio in Q2 2026, its #160 holding.
  • Chemistry Wealth Management first reported a position in Oracle in Q1 2022 and has held it in 18 quarters since.
  • Chemistry Wealth Management's Oracle position peaked at $9.43M in Q3 2025.
  • 1,772 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.